MISSISSAUGA, ON, Nov. 3, 2014 /CNW/ – Nuvo Research Inc. (TSX:NRI), a specialty pharmaceutical company with a diverse portfolio of topical and immunology products, today announced that it plans to commence a Phase 3 clinical study of Pennsaid 2% for the treatment of acute pain to support regulatory approval applications for Pennsaid 2% in international
MISSISSAUGA, ON, Oct. 17, 2014 /CNW/ – Nuvo Research Inc. (TSX:NRI), a specialty pharmaceutical company with a diverse portfolio of topical and immunology products, today announced that it has completed the sale of its PENNSAID 2% U.S. sales and marketing rights to Horizon Pharma plc (NASDAQ:HZNP) for a cash payment ofUS$45 million (CDN$50 million) which was
Continue Reading “Nuvo Research® Sells PENNSAID® 2% U.S. Rights for US$45 Million to Horizon Pharma”
SAN DIEGO, CA–(Marketwired – October 08, 2014) – iWallet Corporation (OTCQB: IWAL), the secure luxury techcessories company, announced it has appointed three new members to its board of directors including Carl Rosen, former COO of Bulova, then international consumer luxury goods company; Charles Ng, VP of sales at NEXT Biometrics and the former North American
Continue Reading “iWallet Appoints Three New Members to Its Board of Directors”
Sherwood Park, Alberta / TNW-ACCESSWIRE / September 30, 2014 / Virtutone Networks Inc. (“Virtutone” or the “Company”) (TSX Venture: VFX.V) is pleased to announce its financial results for the three and six -month period ended July 31, 2014. Click Here
Alabama Graphite Corp. (“Alabama Graphite” or the “Company”) (ALP) (otcqx:ABGPF) (frankfurt:1AG WKN) (ISIN# CA0102931080) is pleased to announce that it has received the first set of metallurgical results from SGS Laboratory in Lakefield, Ontario, Canada on sample material originating from the newly acquired Bama Property. Using only simple floatation (without chemical or thermal treatment) the
Vancouver, BC / TNW-ACCESSWIRE / September 18, 2014 / Alabama Graphite Corp. (the “Company”) (TSX-V:ALP) (OTCQX:ABGPF) (FRANKFURT: 1AG WKN: A1J35M) (ISIN# CA0102931080) is pleased to announce that it has entered into a mineral lease on a land package that includes the prior producing Bama flake graphite Mine in Chilton County, Alabama, USA. The mineral lease comprises 200 acres and
Vancouver, BC / TNW-ACCESSWIRE / September 16, 2014 / Alabama Graphite Corp. (the “Company”) (TSX-V:ALP) (OTCQX:ABGPF) (FRANKFURT: 1AG WKN: A1J35M) (ISIN# CA0102931080) is pleased to report assay results from the summer 2014 sonic drilling program at its Coosa Graphite Project in Alabama, USA. Sonic drilling was chosen because of its ability to drill on established roads without extensive pad
iWallet Corporation (OTCQB: IWAL), the secure luxury techcessories company, has named Jack Chadsey as its new CEO. Chadsey replaces Steve Cabouli, who will continue to serve as President and a member of the Board of Directors. Chadsey’s retail career includes senior executive positions with premier retailers, including May Department Stores Company, Kohl’s, Dayton Hudson, Target
MISSISSAUGA, ON, Sept. 8, 2014 /CNW/ – Nuvo Research Inc. (TSX:NRI), a specialty pharmaceutical company with a diverse portfolio of topical and immunology products, today announced that it has reached a full settlement with Mallinckrodt Inc. of Nuvo’s claims and Mallinckrodt’s counterclaim relating to Nuvo’s license to Mallinckrodt of the right to market and sell Pennsaid® and Pennsaid 2% in the United
Continue Reading “Nuvo Research® settles litigation with Mallinckrodt Pharmaceuticals”
MISSISSAUGA, ON, Sept. 3, 2014 /CNW/ – Nuvo Research Inc. (TSX:NRI), a specialty pharmaceutical company with a diverse portfolio of topical and immunology products, today announced that it has completed enrolment in its Phase 2 clinical trial to investigate the safety and efficacy of WF10 in patients with refractory allergic rhinitis. The Company expects the trial to be
Continue Reading “Nuvo Research® Completes Enrolment in WF10™ Phase 2 Clinical Trial”
